s6y
Company name or ticker
Search
Allogene Therapeutics, Inc.
4
Mayo Stephen: Statement of changes in beneficial ownership of securities
Filed
Tuesday, July 12, 2022
Period
Jul 8, 2022
Accession number
0001737287-22-000053
Documents
PRIMARY DOCUMENT
4
On sec.gov
Filing index
All files
Complete submission text
SGML header